Company Information & Drug Savings for Acorda Therapeutics Inc. Medications

Acorda Therapeutics is a biotechnology company focused on developing therapies for neurological disorders. Headquartered in Ardsley, New York, Acorda is known for Ampyra (dalfampridine), an FDA-approved treatment that improves walking ability in patients with multiple sclerosis (MS). The company specializes in treatments for movement disorders, Parkinson’s disease, and spinal cord injuries, utilizing innovative drug delivery technologies to address unmet needs in neurology.

Acorda Therapeutics Inc.

How to Contact Acorda Therapeutics Inc.

Browse Medications Manufactured by Acorda Therapeutics Inc.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch